Silvestre-Ferreira Ana C, Vilhena Hugo, Oliveira Ana C, Mendoza José R, Aura Maria Garcia, Pastor Josep
Department of Veterinary Sciences, University of Trás-Os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal.
Animal and Veterinary Research Centre (CECAV), University of Trás-Os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal.
Vet Sci. 2024 Sep 22;11(9):449. doi: 10.3390/vetsci11090449.
In dogs, the risk of an acute hemolytic transfusion reaction at the first transfusion is negligible; however, mismatched transfusions may produce alloimmunization. To avoid fatal acute hemolytic reactions in subsequent blood transfusions, it is important to recognize blood groups and to blood type both the donor and the recipient. Prevalence of dog blood groups varies geographically and between breeds. Our aim was to determine DEA 1 prevalence in a canine population in Luanda (Angola) and to assess alloimmunization risk after a mismatched blood transfusion. Blood samples were typed using an immunochromatographic strip technique. Of the 112 dogs tested (59 males; 53 females), 52.68% were DEA 1 positive and 47.32% DEA 1 negative. Females tended to be DEA 1 positive, and males DEA 1 negative ( = 0.0085). In a first-time mismatched blood transfusion, the calculated probability of a dog becoming sensitized was 24.9% and the probability of an acute hemolytic reaction following a second incompatible blood transfusion was 6.21%. DEA 1 prevalence obtained was similar to that reported worldwide, but differs from other African countries. The risk of alloimmunization and acute hemolytic transfusion reactions in mismatched blood transfusions is higher than that in other African regions. Blood typing is recommended prior to transfusion.
在犬类中,首次输血时发生急性溶血性输血反应的风险可忽略不计;然而,血型不匹配的输血可能会导致同种免疫。为避免后续输血中发生致命的急性溶血性反应,识别血型并对供血者和受血者进行血型鉴定很重要。犬类血型的流行率因地理位置和品种而异。我们的目的是确定罗安达(安哥拉)犬类群体中DEA 1的流行率,并评估血型不匹配输血后的同种免疫风险。使用免疫层析试纸技术对血样进行血型鉴定。在测试的112只犬(59只雄性;53只雌性)中,52.68%为DEA 1阳性,47.32%为DEA 1阴性。雌性倾向于DEA 1阳性,而雄性倾向于DEA 1阴性(P = 0.0085)。在首次血型不匹配输血中,犬产生致敏的计算概率为24.9%,第二次不相容输血后发生急性溶血性反应的概率为6.21%。获得的DEA 1流行率与全球报道的相似,但与其他非洲国家不同。血型不匹配输血中同种免疫和急性溶血性输血反应的风险高于其他非洲地区。建议在输血前进行血型鉴定。